Tumor hypoxia is an adverse prognostic factor. In a recent study, we could demonstrate that cyclic hypoxia selects for hypoxia-tolerant tumor cells, which are crossresistant to other stimuli of mitochondrial death pathways. In contrast, sensitivity of the cells to death-receptor ligands was mainly not affected. The aim of the present study was to further elucidate cellular changes induced by cyclic hypoxia and to identify alterations in gene expression pattern upon hypoxic selection by means of DNA-microarray analysis. Our data reveal that cyclic hypoxia resulted in the selection of cells with resistance to doxorubicine and radiation. Furthermore, hypoxic selection was accompanied by constitutive changes of the gene expression pattern with downregulation of 156 and upregulation of 82 genes. Most of the differentially regulated genes were involved in cellular responses to hypoxia and reoxygenation. While many of the genes that were downregulated upon hypoxic selection represent genes that are usually upregulated by acute hypoxia, the genes that were upregulated represent genes that are involved in stress resistance and anti-apoptotic signalling. Most importantly, hypoxic selection was not associated with changes of single apoptosis relevant genes, but with alterations in gene expression levels of a wide variety of genes indicating a more complex adaptation process.
Tumor hypoxia is an adverse prognostic factor. In a recent study, we could demonstrate that cyclic hypoxia selects for hypoxia-tolerant tumor cells, which are crossresistant to other stimuli of mitochondrial death pathways. In contrast, sensitivity of the cells to death-receptor ligands was mainly not affected. The aim of the present study was to further elucidate cellular changes induced by cyclic hypoxia and to identify alterations in gene expression pattern upon hypoxic selection by means of DNA-microarray analysis. Our data reveal that cyclic hypoxia resulted in the selection of cells with resistance to doxorubicine and radiation. Furthermore, hypoxic selection was accompanied by constitutive changes of the gene expression pattern with downregulation of 156 and upregulation of 82 genes. Most of the differentially regulated genes were involved in cellular responses to hypoxia and reoxygenation. While many of the genes that were downregulated upon hypoxic selection represent genes that are usually upregulated by acute hypoxia, the genes that were upregulated represent genes that are involved in stress resistance and anti-apoptotic signalling. Most importantly, hypoxic selection was not associated with changes of single apoptosis relevant genes, but with alterations in gene expression levels of a wide variety of genes indicating a more complex adaptation process. Oncogene (2005) 24, 5914-5922. doi:10.1038/sj.onc.1208748; published online 9 May 2005 Keywords: hypoxia; apoptosis resistance; mitochondria; gene expression pattern; microarray analysis Tumor hypoxia represents a negative prognostic factor and has been associated with increased mutation rates, increased proangiogenic gene expression, increased invasiveness, enhanced metastatic potential as well as treatment failure (Harris, 2002) . The efficacy of radiotherapy and some standard DNA-damaging agents relies on the presence of adequate oxygen concentrations (Gray et al., 1953) . Therefore, either acute or chronic hypoxia may directly interfere with treatment outcome. In addition, hypoxia may also contribute to treatment failure by indirect mechanisms such as upregulation of drug-resistance genes or selection of death-resistant cells (Dong and Wang, 2004; Weinmann et al., 2004b) . In this regard, tumor hypoxia creates a bottleneck situation: since growth and survival of tumor cells critically rely on adequate oxygen supply, severe acute hypoxia can induce cell cycle arrest and cell death, mainly apoptosis, in tumor cells (Weinmann et al., 2004a, c) . Therefore, it is likely that exposure to chronic or to repeated cycles of transient hypoxia may favor the growth of a hypoxia-tolerant cellular phenotype, which is able to cope with hypoxic stress.
In this regard, Graeber et al first established the concept of selection of hypoxia-tolerant and apoptosisdeficient cells by cyclic hypoxia. In their hands, exposure of a quantitatively defined mixture of p53 þ / þ (wild type) and p53À/À (knockout) fibroblasts with a Ras transformed cellular background to repeated cycles of severe hypoxia led to the selection of cells with increased stress tolerance including hypoxia. In this experimental setting, p53-deficient cells overgrew their p53-wild type counterparts (Graeber et al., 1996) .
Similarly, data of Magnusson support the association of hypoxic selection with loss of p53 function. They could show that the conversion of relatively wellvascularized solid mouse tumors into freely growing ascitic cell variants, which are severely hypoxic, favors cells with mutated p53 (Magnusson et al., 1998) .
To gain further insight into the molecular mechanisms of hypoxic selection, we recently developed an in vitro model of hypoxia-tolerant NCI H460 lung carcinoma cells by cyclic exposure to 10 cycles (48 h) of severe hypoxia (0.1% O 2 ) and reoxygenation (120 h) (Weinmann et al., 2004b) . We could show that cyclic hypoxia led to the selection of tumor cells with resistance to hypoxia-induced apoptosis. Importantly, hypoxic selection conferred cross-resistance to apoptosis induction by irradiation and treatment with etoposide, which both induce apoptosis via the mitochondrial death pathway. In contrast, the hypoxia-tolerant cells were still susceptible to TRAIL, a paradigmatic stimulus of the death receptor pathway.
Further investigations revealed that hypoxia-tolerant NCI H460 cells exhibited defects in the signalling cascade of the mitochondrial death pathway. Importantly, conformational changes of Bax upon exposure to ionizing radiation were disturbed. Furthermore, hypoxia-tolerant cells failed to release cytochrome c from the mitochondria and to activate caspases upon irradiation. In contrast to the above-mentioned studies, hypoxic selection of hypoxia-tolerant NCI H460 lung carcinoma cells with defects in mitochondrial apoptotic pathways was not associated with a loss of p53 function (Weinmann et al., 2004b) .
The putative clinical relevance of the evolution of an apoptosis-deficient phenotype by means of hypoxic selection in respect to treatment failure is strongly corroborated by some clinical data. Analysis of the oxygenation profiles and apoptotic indices in human squamous cell cancer of the uterine cervix led to the identification of a subgroup of tumors with low apoptotic index despite pronounced hypoxia. These hypoxic low-apoptotic tumors showed a high probability for lymphatic spread and for recurrence despite adjuvant treatment with radiation or chemotherapy in addition to radical surgery (Hockel et al., 1999) .
These findings suggest that hypoxia-mediated selection of hypoxia-tolerant phenotypes may rely on the elimination of cells, which are sensitive to hypoxiainduced cell death. However, it has to be taken into account that hypoxia clearly contributes to genetic instability and thereby to increased genetic diversity of tumor cells (Rockwell et al., 2001) . Thus, complex genetic alterations leading to altered expression of proteins involved in apoptosis signalling pathways or the cellular stress response may also be operative. Therefore, the aim of the present study was to further elucidate the changes induced by hypoxic selection at the cellular and molecular level.
In a first set of experiments we verified apoptosis resistance of hypoxia-tolerant NCI H460 cells (Figure 1 ). Exposure to 10 cycles of hypoxia and reoxygenation led to selection of cells with increased tolerance to hypoxiainduced apoptosis (Figure 1a) .
Furthermore, hypoxic selection rendered tumor cells more resistant to apoptosis induction by ionizing radiation (Figure 1b) . In this regard, even culturing of the hypoxia-selected cells for 2 weeks after the 10th cycle under ambient O 2 conditions did not reverse the apoptosis-resistant phenotype arguing against a transient phenomenon (Figure 1b) .
To further establish the concept that cyclic hypoxia may select for a more general resistance to stimuli of the mitochondrial death pathway, we characterized the sensitivity of hypoxia-tolerant NCI H460 cells to apoptosis induction in response to the standard chemotherapeutic drug doxorubicine, which similar to hypoxia and irradiation induces apoptosis via the mitochondrial death pathway (Gruber et al., 2004) . While unselected NCI H460 cells turned out to be highly sensitive to doxorubicine-induced apoptosis, apoptotic rates were reduced in the hypoxia-tolerant cells. Thus, in addition to resistance to etoposide, which was shown in a previous study (Weinmann et al., 2004b) , our hypoxia-tolerant cells showed crossresistance to doxorubicine (Figure 1c ).
Up to now our data indicated that in contrast to the highly sensitive control cells, hypoxia-tolerant NCI H460 cells show broad resistance to various stimuli of the mitochondrial death pathway. Apoptosis resistance was not a transient phenomenon but was retained in cells cultured for at least 2 weeks under ambient O 2 conditions. These data point to the selection of a distinct phenotype implicating the involvement of genetic alterations.
To determine in how far selection of hypoxia-tolerant cells was associated with changes of gene expression patterns, a DNA microarray analysis was performed comparing whole-cell RNA from hypoxiatolerant NCI H460 cells selected by 10 consecutive cycles of hypoxia and reoxygenation to whole-cell RNA from control NCI H460 cells, which were grown under normoxic conditions. Gene expression was analysed by means of DNA microarray technique using the Affymetrix Human genome U133A array, which encompasses 22 283 known human genes and expressed sequence tags.
Our data reveal complex alterations in gene expression pattern with a variety of differentially expressed genes upon hypoxic selection: using nine pairwise comparisons of gene expression, 82 of the 22 283 probe sets representing single genes were reproducibly and significantly upregulated (range 2.2 to 14.57-fold) while 156 genes were consistently downregulated (range À2.2 to À18.53-fold) after hypoxic selection in all nine of nine pairwise comparisons. A comprehensive list of all differentially regulated genes in nine of nine and eight of nine pairwise comparisons is provided on our homepage (www.radiation-research.de). Only these sequences, which met the most stringent criteria (nine of nine), were considered for further analysis. The standardization for sample loading and variations in staining by scaling the average of the fluorescence intensities of all genes on one array to a constant target intensity (150) for all arrays allows a semiquantitative evaluation of expression of single genes.
To get insight in putative genes involved in the altered cellular phenotype, expression of genes with known function in the cellular response to hypoxia or apoptosis signalling was analysed in more detail. To this end, genes were further categorized regarding the molecular function based on the NetAffx database (http:// www.NetAffx.com) using the gene ontology program (Liu et al., 2003) . According to the Netaffxt gene ontology (GO) program 13 852 (62%) of the 22 283 probe sets have a known annotated molecular function. Regarding the differentially regulated genes, 60 of the 82 upregulated probe sets (73%) and 116 of the downregulated 156 probe sets (74%) were annotated in known biological processes of the cell, comprising a wide variety of different biological processes such as receptor signalling, protein binding, cell adhesion, regulation of transcription and apoptosis signalling. Furthermore, genes coding for proteins with catalytic activities, transport activities, chaperone activities, nucleotide and nucleic acid binding activities as well as structural components of the cell and extracellular matrix were also affected. This may be an indication for the biological relevance of the changes in gene regulation upon hypoxic selection. For an overview, differentially regulated genes with annotated function in biological processes were grouped according to their molecular function and depicted in Table 1 . Figure 1 Cyclic hypoxia leads to the selection of cells with increased resistance to stimuli of the mitochondrial death pathway. NCI H460 cells (ATCC, Bethesda, Maryland, USA) were cultured under ambient O 2 conditions (control cells, P0) or alternatively exposed to 10 cycles of hypoxia (48 h; GasPak 100, Becton Dickinson, Heidelberg, Germany) and reoxygenation (120 h) (hypoxia-tolerant cells, P10). For some experiments after the 10th hypoxic cycle, P10 cells were subsequently cultured for 2 weeks under ambient O 2 conditions. Sensitivity of the cells to apoptosis induction was determined by quantification of caspase-activation using FACS-analysis (FACS Calibur flow cytometer, Becton Dickinson, Heidelberg, Germany) with the CaspAce s detection system (Promega, Mannheim, Germany) according to the manufacturers guidelines (a-c). Increased fluorescence intensity (Fl1) is indicative for caspase-activation (M2). Moreover, apoptosis was quantified by fluorescence microscopy upon staining of the nuclei with Hoechst 33342 (a, b) as described elsewhere (Weinmann et al., 2004b) . In addition, apoptosis was quantified measuring the breakdown of the mitochondrial transmembrane potential (DC m ) as described previously (c) (Weinmann et al., 2004b) . As some genes are attributed to more than one group, the number of genes listed in the table is higher than 60 or 116, respectively. Gene expression profiles of NCI H460 cells was determined before and after hypoxic selection using Affymetrix microarray analysis. Total RNA was extracted from the 5 Â 10 6 cells per sample by using RNeasy kits (Qiagen, Hilden, Germany). The RNA quality was controlled by Lab-on-Chip-System Bionanalyser 2100 (Agilent, Palo Alto, USA). First-and second-strand cDNA was synthesized from 5-15 mg of total cell RNA using the SuperScript Double-Stranded cDNA Synthesis Kit (Life Technologies, Inc., Rockville, MD, USA) and an oligo-dT24-T7 primer and was then used to prepare cRNA that was labeled with biotinylated UTP and CTP by in vitro transcription using a T7 promoter-coupled double-stranded cDNA as template and the T7 RNA Transcript Labeling Kit (ENZO Diagnostics, Inc., Farmingdale, NY, USA). After purification and precipitation at À201C, 20 mg of this cRNA was fragmented by heat and ion-mediated hydrolysis at 941C (200 mM Tris-acetate (pH 8.1), 500 mM KOAc, 150 mM MgOAc) and hybridized to the Human Genome U133A oligonucleotide array chip (Affymetrix, Santa Clara, CA, USA). U133A contains 22 280 full-length annotated genes together with additional probe sets designed to represent EST sequences. Arrays were washed at 251C with 6 Â saline sodium phosphate-EDTA (0.9 M NaCl, 60 mM NaH 2 PO 4 , 6 mM EDTA+0.01% Tween-20) followed by a stringent wash at 501C with 100 mM MES, 0.1 M [Na + ], 0.01% Tween-20. We then stained arrays with phycoerythrinconjugated streptavidin (Molecular Probes), and the fluorescence intensities were determined using a laser confocal scanner (Agilent, Affymetrix). The scanned images were analysed using Microarray software (Affymetrix). We standardized for sample loading and variations in staining by scaling the average of the fluorescence intensities of all genes on an array to a constant target intensity (150) for all arrays used. The signal intensity for each gene was calculated as the average intensity difference, represented by P (PMÀMM)/(number of probe pairs), where PM and MM denote perfect match and mismatch probes. Affymetrix Microarray Suite software (version 5.0), MicroDB and Data Mining Tool were used to scan and analyse the relative abundance of each gene based on the intensity of the signal from each probe set. Analysis parameters used by the software were set to values corresponding to moderate stringency (statistical difference threshold ¼ 30, statistical ratio threshold ¼ 1.5). Output from the microarray analysis was merged with the Unigene or GenBank descriptor and saved as an Excel data spreadsheet. We ran three arrays for each group analysing three independent samples of cells after 10 cycles of hypoxia and reoxygenation vs three controls allowing a total of nine comparisons (3 Â 3 matrix). For each comparison, the analysis using the Affymetrix software generates a 'difference call' of no change, marginal increase/decrease, or increase/decrease, respectively. Only those genes that were found in nine of nine comparisons similarly adjusted were defined as differentially expressed genes. Further categorization was based on the NetAffx database (http://www.NetAffx.com) (Liu et al., 2003) Gene expression pattern of hypoxia-selected tumor cells M Weinmann et al In addition, the 25 genes with the most significant upor downregulation after hypoxic selection are listed in Tables 2a and 2b, respectively. Among the 116 downregulated genes (negative regulation factor) were a least 17 genes (15%), which are known to be induced by acute hypoxia. These hypoxia-inducible genes encompass six known target genes of the hypoxia inducible factor 1 (HIF-1) (insulinlike growth factor binding protein 3; matrix metalloproteinase-1; CD73; vascular endothelial growth factor C; stanniocalcin; urokinase-type plasminogen activator receptor) (Synnestvedt et al., 2002; Leonard et al., 2003; Semenza, 2003) , 10 target genes of the hypoxia-inducible transcription factor NFkB (interleukin-1, interkeukin-6, interleukin-8, interleukin 18 receptor 1, manganese superoxide dismutase, tissue factor pathway inhibitor-2, CD55, UDP-glucose ceramide glycosyl transferase, immediate early response gene 3; syndecan 4) (Collard et al., 1997; Kacimi et al., 1998; Matsui et al., 1999; Baltathakis et al., 2001; Kojima et al., 2001; Chandrasekar et al., 2003; Guo et al., 2003; Konduri et al., 2003) and two other genes which are also known to be induced under acute hypoxia (cytosolic phospholipase A2; N-CAM) (Gordon et al., 1990; Fujise et al., 2000; Ichinose et al., 2002) . Moreover, the hypoxia-inducible transcription factor HIF-2a/endothelial PAS domain protein (EPAS-1) and a protein, which is involved in NF-kB-activation (CARD-containing ICE associated kinase (CARDIAK) (Kobayashi et al., 2002) , were also down-regulated upon hypoxic selection. Absulute signal intensities as well as the relative changes in signal intensity of single differentially regulated genes upon hypoxic selection that are known to be induced under conditions of acute hypoxia as targets of HIF-1 or NFkB are depicted in Table 2c .
In contrast, among the genes that are upregulated upon hypoxic selection no known hypoxia-regulated genes could be found, but two genes whose expression (aldehyde dehydrogenase 3) (Reisdorph and Lindahl, 1998) or activity (lipoprotein lipase) (Mochizuki et al., 1987) is usually downregulated under acute hypoxia.
In addition, a variety of the upregulated genes are known to be involved in apoptosis regulation and stress signalling (MAPKK6, calmodulin, MARCKS, dystrophin) (Mehler et al., 1992; Bode et al., 1999; Kuperstein et al., 2001; Seta et al., 2002) , the protective cellular response to oxidative stress and/or the metabolism of reactive oxygen species (ROS) (glutathione-S-transfer- Absolute signal intensities corresponding to the absolute amount of mRNA expression and relative changes of gene expression levels (regulation factor) are provided (upregulation: positive regulation factor; downregulation: negative regulation factor). Ranking was performed according to the amount of the relative alteration of gene expression among all differentially expressed genes. The regulation factors of all nine pairwise comparisons were analysed by the Mann-Whitney test using SPSS 10.0 statistical software. The standard deviation (s.d.) and the P-values of this calculation are provided in the table. Gene bank numbers were given according to http://www.ncbi.nlm.nih.gov ase, glutathione peroxidase 3, heme oxygenase-1, cytochrome B5 reductase (diaphorase) (Di Ilio et al., 1996; Poss and Tonegawa, 1997; Lenaz et al., 2002; Fan et al., 2003) . A list of the absolute signal intensities as well as the relative changes in signal intensity of all differentially regulated genes upon hypoxic selection that are known to be involved in compensatory reactions to cellular stress and apoptosis is provided in Table 2d . Particularly, the expression of 15 different genes coding for oxido-reductases was influenced by hypoxic selection pointing to an altered metabolism of ROS in hypoxia-tolerant cells (cf Table 1 ). Since radiationinduced radicals contribute significantly to the fixation of radiation-induced DNA-damage, upregulated activity of these enzymes may contribute to protection against ionizing radiation. It has been shown that diaphorase is involved in the intracellular activation of hypoxic cytotoxins such as mitomycin C by reduction under hypoxic conditions (Weinmann et al., 2003) . Thus, increased intracellular activity of diaphorase in hypoxia-tolerant cells may render these cells more vulnerable to hypoxic cytotoxins.
Furthermore, an altered expression of proteins with putative function in apoptosis signalling with downregulation of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; IER3) (Arlt et al., 2003) and upregulation of heat shock protein-70 (Hsp70) and Bag-1 was also detected in hypoxia-tolerant cells as compared to the unselected hypoxia-sensitive control cells.
Amazingly, none of the dysregulated genes is known to be a key player for mitochondrial apoptosis regulation. However, two of the upregulated genes, Hsp70 and Bag-1, have been suggested to be involved in negative regulation of apoptosis signalling. In this context, the major stress-inducible heat shock protein, Hsp70, constitutes a chaperone protein, which is abundantly and preferentially expressed in human tumors. Hsp70 is usually expressed in response to a wide variety of stressors and allows cells to survive in adverse environmental conditions (Jaattela, 1999) . In this context, Hsp70 inhibits key effectors of the apoptosis machinery including Apaf-1 and apoptosis inducing factor (AIF), which may at least partially explain enhanced tolerance against triggers of the mitochondrial apoptotic pathway Absolute signal intensities corresponding to the absolute amount of mRNA expression and relative changes of gene expression levels (regulation factor) are provided (upregulation: positive regulation factor; downregulation: negative regulation factor). Ranking was performed according to the amount of the relative alteration of gene expression among all differentially expressed genes. The regulation factors of all nine pairwise comparisons were analysed by the Mann-Whitney test using SPSS 10.0 statistical software. The standard deviation (s.d.) and the P-values of this calculation are provided in the table. Gene bank numbers were given according to http://www.ncbi.nlm.nih.gov (Beere et al., 2000) . Moreover, Hsp70 plays a role in the proteasome-mediated degradation of apoptosis-regulatory proteins (Garrido et al., 2003) . Bag-1 is the second gene with putative apoptosisinhibitory function, which is upregulated upon hypoxic selection. This multifunctional protein interacts with a wide range of cellular targets to regulate growth control pathways important for normal and malignant cells including apoptosis, proliferation, transcription as well as cell motility. Bag-1 has been shown to interact with The impact of hypoxic selection on the expression of single genes known to be involved in the cellular response to hypoxia according to literature search and NetAffx database (http://www.NetAffx.com) using the gene ontology program (Liu et al., 2003) . Absolute signal intensities (corresponding to the absolute amount of mRNA expression) and relative changes of gene expression levels (regulation factor) are provided (upregulation: positive regulation factor; downregulation: negative regulation factor; ranking was performed according to the amount of relative alteration of gene expression among all differentially expressed genes). Gene bank numbers were given according to http://www.ncbi.nlm.nih.gov The impact of hypoxic selection on the expression of single genes known to be involved in the cellular response to oxidative or proapoptotic stress according to literature search and NetAffx database (http://www.NetAffx.com) using the gene ontology program (Liu et al., 2003) . Absolute signal intensities corresponding to the absolute amount of mRNA expression and relative changes of gene expression levels (regulation factor) are provided. (upregulation: positive regulation factor; downregulation: negative regulation factor; ranking according to the amount of relative alteration of gene expression among all differentially expressed genes). Gene bank numbers were given according to http://www.ncbi.nlm.nih.gov the antiapoptotic protein Bcl-2, various nuclear hormone receptors and the 70 kDa heat shock proteins, Hsc70 and Hsp70. In this context, Bag-1 constitutes a regulatory cofactor of Hsp70 protein folding and/or proteasomal proteolysis (Luders et al., 2000) . Overexpression of Bag-1 protected cells against apoptosis and growth inhibition induced by stress stimuli such as heat shock, hypoxia, radiation and chemotherapeutic drugs that are known to induce apoptosis via the mitochondrial death pathway. In contrast, Bag-1 overexpression had only a minor impact on TRAIL-induced apoptosis (Townsend et al., 2003) . Thus, upregulated expression of Hsp-70 and Bag-1 may contribute to the resistance of hypoxia-tolerant NCI H460 cells to stimuli of the mitochondrial death pathway.
In contrast to a recent publication that provided evidence for hypoxia-induced selection of apoptosisresistant immortalized rat kidney epithelial cells, which was associated with an upregulated expression of the antiapoptotic Bcl-2 family member Bcl-x L (Dong and Wang, 2004), we did not observe increased expression of Bcl-x L in our hypoxia-tolerant NCI H460 tumor cell model. In addition, no downregulation of proapoptotic proteins like Bax, Bim or Puma was observed after hypoxic selection in this model system (Weinmann et al., 2004b) . Therefore, hypoxia-induced specific alterations in gene expression pattern may be strongly dependent on the cellular system.
It is remarkable, that most of the differentially regulated genes are involved in cellular responses to hypoxia and reoxygenation. This may indicate that the changes in gene expression pattern do not occur at random, but reflect an adaptive process with functional relevance. Interestingly, most of the genes that are downregulated in hypoxia-tolerant cells constitute genes that are under the transcriptional regulation of the transcription factors HIF-1 and NFkB, which are both induced by acute hypoxia and regulate the expression of a broad range of target genes. This may be an indication for a functional role of hypoxia-inducible transcription factors in the process of hypoxic selection and induction of stress tolerance. In contrast, those genes that were upregulated by hypoxic selection represent genes that are generally involved in stress resistance and antiapoptotic signalling.
However, it is still unclear whether the apoptosisresistant phenotype of hypoxia-selected cells is caused by the altered expression of some few key players known to be involved in the cellular stress response (e.g. Hsp70, proteins involved in ROS-metabolism) or whether the complex pattern of differentially regulated genes as a whole will generate the apoptosis-deficient phenotype of hypoxia-selected cells. Further functional studies will address this issue.
In summary, our results clearly indicate that multiple cycles of hypoxia and reoxygenation create a hypoxiatolerant cellular phenotype, which is associated with broad resistance to stimuli of the mitochondrial death pathway. The key observation is that the increased apoptosis resistance of the selected hypoxia-tolerant cells is accompanied by complex constitutive changes of the cellular gene expression pattern. The phenomenon of hypoxia-induced selection of tumor cells resistant to genotoxic therapies may at least partially explain the fact that strategies aiming at the improval of tumor oxygenation during radiotherapy often fail to reverse the negative outcome of hypoxic tumors. A better understanding of the gene alterations induced by hypoxic selection and of the mechanisms involved in hypoxia-induced therapy resistance may provide a rationale for the use of targeted treatment approaches that specifically bypass the resistance implemented in solid human tumors and reduce the risk of hypoxiamediated treatment failure in the future.
